Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • chouech
    Junior Member
    • Jul 2014
    • 2

    differential expression analysis for low coverage datasets

    Hi,

    I have RNAseq data with 1.5 M reads. But the general transcriptome coverge is very low. The percentage of gene covered over 70% at a given expression level is 20% only!

    So I was thinking that for differential expression analysis I'll get low power because I've got a lot of gene with low coverage that may be false positive...

    Do you think it could be a good idea to keep for differential analysis only gene with a moderate coverage like at least 50%??

    When I do this I can found more differentially expressed gene! (7 instead of 2)

    If someone has an opinion on this...
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    1) It would be helpful to know what organism you're using.
    2) Regardless, 1.5M reads very low for a good DE experiment in anything larger than a bacteria (and low even for a bacteria). It would only be informative about a handful of genes. And your 'coverage' metric is less useful than knowing the total number of reads mapped to a gene.

    It sounds to me like you should generate a lot more data if you want useful results.

    Comment

    • chouech
      Junior Member
      • Jul 2014
      • 2

      #3
      It's a fungal genome: Magnaporthe (40 Mbp) but I can't sequence more data... so I was thinking to try to do with what I have analysing only genes that have enough mapped reads... the problem is to choose a threshold. That's why I was thinking to keep only gene that are 50% covered at least... but that's true that is some part of the gene that may represent only 1 read!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      215 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      79 views
      0 reactions
      Last Post SEQadmin2  
      Working...